开始
RocketTickers

FDA approves Lyumjev(TM) (insulin lispro-aabc injection), Lilly'

做多
Eli Lilly and Company (NYSE:LLY)  
RocketTickers  
NYSE:LLY   Eli Lilly and Company
Beyond Technical Analysis
5
0
beyondta
LLY: Eli Lilly and Company
2020-06-15 22:21:00
FDA approves Lyumjev(TM) (insulin lispro-aabc injection), Lilly's new rapid-acting insulin
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。